medicines
AFTINET | 5-Nov-2015
Preliminary analysis of the thousands of pages of the main chapters of the TPP text show there are still devils in the detail on medicine monopolies, investor rights to sue governments and copyright monopolies.
keywords:
actions | resistance ,
CPTPP ,
intellectual property ,
investor-state disputes | ISDS ,
medicines
Red del Tercer Mundo | 16-Oct-2015
Finalmente concluyeron las negociaciones sobre el Acuerdo de Asociación Transpacífico (TPP). Si bien el texto oficial aún no se ha hecho público, a partir de informes de prensa y textos filtrados pueden hacerse algunos comentarios preliminares. En primer lugar, el comercio es solo una parte del TPP.
SSRN | 1-Oct-2015
Despite the deep irony of free trade agreements being subverted to codify and extend anti-competitive monopoly rights the joining of enhanced intellectual property rights (IPRs) and strengthened investor rights is creating a wild-west opportunity for unbounded corporate power.
Biodiversidad en América latina | 14-Sep-2015
Los presidentes de Chile, México y Perú recibieron una carta pública por las negociaciones secretas en torno al Tratado de Asociación Transpacífica (TPP) y sus implicancias para el futuro de los consumidores.
AFTINET | 14-Sep-2015
While RCEP was initially framed as an agreement that would be more flexible for low and middle income countries, there is evidence that some governments from industrialised countries are seeking to pursue aspects which would be very damaging for developing countries.
keywords:
actions | resistance ,
intellectual property ,
investor-state disputes | ISDS ,
medicines ,
RCEP
FT Alphaville | 26-Aug-2015
Joseph Stiglitz, the Nobel Prize-winning economist, discusses TPP.
Foreign Policy | 8-Jul-2015
Oone issue that has received comparatively little attention is how the Trans-Pacific Partnership is likely to impact the developing countries slated to join.
The Dominion Post | 6-Jul-2015
New Zealand needs to be ready to walk away from the Trans Pacific Partnership, says The Domion Post, worried about the impact of its drug patenting rules and investor-state dispute settlement mechanism.
Scoop | 30-Jun-2015
The Australian government misrepresents the claims of critics and fails to address substantial criticisms of the Trans Pacific Partnership, says civil society network AFTINET.
keywords:
actions | resistance ,
Australia ,
CPTPP ,
environment ,
food safety | SPS ,
investor-state disputes | ISDS ,
medicines
Australia Broadcasting Corporation | 19-Mar-2015
Australia’s primary negotiator on medicines for the US-Australia FTA, Dr Ruth Lopert, warns that the TPP could force the Australian Government to spend hundreds of millions of dollars to subsidise medicines.
